首页> 外文会议>Annual Conference and Expo of the Institute of Industrial Engineers >Product Platform Approach to Personalized Type 2 Diabetes Mellitus Management
【24h】

Product Platform Approach to Personalized Type 2 Diabetes Mellitus Management

机译:产品平台的个性化2型糖尿病Mellitus Management方法

获取原文

摘要

Type 2 diabetes mellitus (T2DM) is one of the most common chronic disease and the seventh leading cause of death in the United States. Casting T2DM in a product platform framework, this research aims to establish the relationships between contributing factors and complications. Once the tree structure is created by analyzing the historical patient data, patients are clustered based on their complication characteristics and the contributing factors, such as age, race, blood pressure, glycemic levels, and hemoglobin levels. Along with patient clustering, treatment plans are also clustered simultaneously. This creates a mapping between patient groups and treatment groups, with one optimal treatment plan for each cluster of patients. When an individual patient's membership is determined, the association between the patient and the optimal treatment plan is automatically identified. The healthcare providers can tailor the treatment plan based on the individual's unique needs. The proposed approach is a more efficient way to treat T2DM patients than the current traditional approach. It also offers flexibility to customize the treatment plans for each individual patient without undue effort.
机译:2型糖尿病(T2DM)是最常见的慢性疾病之一和美国死亡的第七名。在产品平台框架中铸造T2DM,这项研究旨在建立贡献因素和并发症之间的关系。一旦通过分析历史患者数据来创建树结构,患者基于其并发症特征和贡献因素,例如年龄,种族,血压,血糖水平和血红蛋白水平。随着患者聚类,处理计划也同时聚集。这在患者组和治疗组之间产生了一种映射,为每个患者的一个最佳治疗计划进行了一种最佳的治疗计划。当确定个体患者的成员资格时,患者与最佳治疗计划之间的关联被自动识别。医疗保健提供者可以根据个人的独特需求来定制治疗计划。该方法是一种更有效的方法来治疗T2DM患者而不是目前的传统方法。它还可以灵活地为每个患者定制治疗计划,而不会努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号